Van Bellinghen LA - Search Results

1

The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.

Van Bellinghen LA, Meier G, Van Vlaenderen I. Van Bellinghen LA, et al. Among authors: van vlaenderen i. PLoS One. 2014 Jun 6;9(6):e98437. doi: 10.1371/journal.pone.0098437. eCollection 2014. PLoS One. 2014. PMID: 24905235 Free PMC article.

2

An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static models.

Van Vlaenderen I, Van Bellinghen LA, Meier G, Nautrup BP. Van Vlaenderen I, et al. Among authors: van bellinghen la. BMC Infect Dis. 2013 Jan 22;13:25. doi: 10.1186/1471-2334-13-25. BMC Infect Dis. 2013. PMID: 23339290 Free PMC article.

3

Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study.

Sauboin CJ, Van Bellinghen LA, Van De Velde N, Van Vlaenderen I. Sauboin CJ, et al. Among authors: van bellinghen la, van de velde n, van vlaenderen i. Malar J. 2015 Dec 23;14:524. doi: 10.1186/s12936-015-1046-z. Malar J. 2015. PMID: 26702637 Free PMC article. Clinical Trial.

4

Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model.

Dolk C, Eichner M, Welte R, Anastassopoulou A, Van Bellinghen LA, Poulsen Nautrup B, Van Vlaenderen I, Schmidt-Ott R, Schwehm M, Postma M. Dolk C, et al. Among authors: van bellinghen la. Pharmacoeconomics. 2016 Dec;34(12):1299-1308. doi: 10.1007/s40273-016-0443-7. Pharmacoeconomics. 2016. PMID: 27647004 Free PMC article.

5

Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil - comparison of outcomes from different static model types.

Van Bellinghen LA, Marijam A, Tannus Branco de Araujo G, Gomez J, Van Vlaenderen I. Van Bellinghen LA, et al. Braz J Infect Dis. 2018 Jan-Feb;22(1):1-10. doi: 10.1016/j.bjid.2017.11.004. Epub 2018 Jan 18. Braz J Infect Dis. 2018. PMID: 29352897 Free PMC article.

6

Reducing Malaria Mortality at the Lowest Budget: An Optimization Tool for Selecting Malaria Preventative Interventions Applied to Ghana.

Sauboin C, Van Vlaenderen I, Van Bellinghen LA, Standaert B. Sauboin C, et al. Among authors: van bellinghen la. MDM Policy Pract. 2019 Jul 25;4(2):2381468319861346. doi: 10.1177/2381468319861346. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31384668 Free PMC article.

7

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project.

Standaert B, Van Vlaenderen I, Van Bellinghen LA, Talbird S, Hicks K, Carrico J, Buck PO. Standaert B, et al. Among authors: van bellinghen la. Appl Health Econ Health Policy. 2020 Aug;18(4):519-531. doi: 10.1007/s40258-019-00534-y. Appl Health Econ Health Policy. 2020. PMID: 31755016 Free PMC article.

8

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries.

Sauboin C, Van Bellinghen LA, Van De Velde N, Van Vlaenderen I. Sauboin C, et al. Among authors: van bellinghen la. MDM Policy Pract. 2019 Dec 10;4(2):2381468319873324. doi: 10.1177/2381468319873324. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31853505 Free PMC article.

9

Constrained Optimization for Pneumococcal Vaccination in Brazil.

Olbrecht J, Gomez JA, Van Bellinghen LA, Van Vlaenderen I, Standaert B. Olbrecht J, et al. Among authors: van bellinghen la. Value Health Reg Issues. 2021 Dec;26:40-49. doi: 10.1016/j.vhri.2020.11.011. Epub 2021 Apr 10. Value Health Reg Issues. 2021. PMID: 33848895 Free article.

10

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.

Molnar D, Anastassopoulou A, Poulsen Nautrup B, Schmidt-Ott R, Eichner M, Schwehm M, Dos Santos G, Ultsch B, Bekkat-Berkani R, von Krempelhuber A, Van Vlaenderen I, Van Bellinghen LA. Molnar D, et al. Among authors: van bellinghen la. Hum Vaccin Immunother. 2022 Nov 30;18(5):2058304. doi: 10.1080/21645515.2022.2058304. Epub 2022 Apr 29. Hum Vaccin Immunother. 2022. PMID: 35486410 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page